查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
疫苗佐剂市场，按产品类型、按应用、按使用类型、按疾病领域、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419053

疫苗佐剂市场，按产品类型、按应用、按使用类型、按疾病领域、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Vaccine Adjuvants Market, By Product Type, By Application, By Usage Type, By Disease Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年疫苗佐剂市场规模为 7.125 亿美元，2023 年至 2030 年复合CAGR为 7.2%。

疫苗佐剂市场-市场动态

传染病发生率上升推动市场需求

流感、结核病、霍乱、小儿麻痹、麻疹、疟疾和爱滋病毒等传染病的盛行率不断上升。据世界卫生组织称，结核病是全球第13 大死亡原因，并在2021 年成为仅次于COVID-19 的第二大传染病死亡原因，全球报告死亡人数近160 万人，其中包括187,000 名爱滋病毒感染者。病例激增给疫苗生产带来了巨大压力，因为对抗此类传染病所需的疫苗数量不断增加，从而增加了对佐剂的需求。

疫苗佐剂市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 7.2% 左右的CAGR成长
  • 根据产品类型细分，预计助剂乳剂将在 2022 年显示最大的市场份额
  • 从应用细分来看，2022年商用为主导类型
  • 根据使用类型细分，活性免疫增强剂是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

疫苗佐剂市场-区隔分析：

全球疫苗佐剂市场根据产品类型、应用、使用类型、疾病领域和地区进行细分。

依产品类型，市场分为八类：矿物盐佐剂、张力活性佐剂、乳液佐剂、脂质体佐剂、碳水化合物佐剂、细菌源佐剂、病毒样颗粒（VLP）等。根据产品分类，预计佐剂乳剂细分市场将在预测期内保持领先地位。这主要归因于传染病患者病率的不断上升，推动了疫苗中乳剂佐剂的使用，从而促进了这一特定领域的扩张。

市场依应用分为两类：研究型和商业型。商业部门主导市场，并可能在预测期内保持其主导地位。随着传染病的增加和全球持续的公共卫生问题，对有效疫苗的需求日益增长。佐剂对开发提供更好保护的疫苗做出了重大贡献，使医疗保健系统能够扩大疫苗接种计划，特别是在传染病高发地区。

疫苗佐剂市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

疫苗佐剂市场-竞争格局：

疫苗佐剂市场目前正在经历旨在提高疫苗功效和安全性的策略进步。这些创新集中在开创性的佐剂配方和输送系统，旨在增强免疫反应，同时维护安全标准。大量的研究和开发工作旨在专门针对不同的疫苗客製化佐剂，从而增强其在不同人群中的有效性。此外，製药公司、研究机构和监管机构之间的合作正在推动佐剂的开发和验证，特别是针对新出现的传染病和具有挑战性的病原体。市场动态围绕着监管遵守、成本效率和可扩展性，为加强疫苗反应并促进全球公共卫生改善的变革性佐剂技术奠定了基础。

最近的发展：

2023 年1 月，专注于淋巴结靶向佐剂以及针对暴力癌症和传染病的疫苗的Elicio Therapeutics 与Angion Biomedica Corp 敲定了一项联盟协议。重点在于推进Elicio 独特的淋巴结靶向Amphiphile 专业知识，以取得进展免疫疗法，主要集中在 ELI-002，这是一种针对 mKRAS 驱动的肿瘤的治疗性癌症疫苗。

2022年11月，Hubro Therapeutics AS透过资产购买协议从Targovax ASA收购了GM-CSF疫苗佐剂，涉及现金1,000万挪威克朗。 Hubro 正在继续开发 GM-CSF，作为其管道中一系列创新癌症疫苗的佐剂。

目录

第一章：疫苗佐剂市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的疫苗佐剂市场片段
    • 疫苗佐剂市场片段（依应用）
    • 依使用类型分類的疫苗佐剂市场片段
    • 按疾病领域分類的疫苗佐剂市场片段
    • 按国家/地区分類的疫苗佐剂市场摘要
    • 按地区分類的疫苗佐剂市场片段
  • 竞争洞察

第 3 章：疫苗佐剂主要市场趋势

  • 疫苗佐剂市场驱动因素
    • 市场驱动因素的影响分析
  • 疫苗佐剂市场限制
    • 市场限制影响分析
  • 疫苗佐剂市场机会
  • 疫苗佐剂市场未来趋势

第 4 章：疫苗佐剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：疫苗佐剂市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：疫苗佐剂市场格局

  • 2022 年疫苗佐剂市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：疫苗佐剂市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 矿物盐佐剂
    • 张力活性佐剂
    • 佐剂乳剂
    • 脂质体佐剂
    • 碳水化合物佐剂
    • 细菌来源的佐剂
    • 病毒样颗粒 (VLP)
    • 其他的

第 8 章：疫苗佐剂市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 研究应用
    • 商业应用

第 9 章：疫苗佐剂市场 - 依使用类型

  • 概述
    • 按使用类型分類的细分市场份额分析
    • 活性免疫增强剂
    • 营运商
    • 车用助剂

第 10 章：疫苗佐剂市场 - 按疾病领域

  • 概述
    • 按应用的细分市场占有率分析
    • 传染病
    • 癌症
    • 其他的

第 11 章：疫苗佐剂市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美疫苗佐剂主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按使用类型）
    • 北美市场规模与预测（按疾病领域）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲疫苗佐剂主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按使用类型）
    • 欧洲市场规模与预测（按疾病领域）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区疫苗佐剂主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按使用类型）
    • 亚太地区市场规模与预测（按疾病领域）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗佐剂主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按使用类型）
    • 拉丁美洲市场规模与预测（按疾病领域）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲疫苗佐剂主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按使用类型）
    • 中东和非洲市场规模及预测（按疾病领域）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 疫苗佐剂产业

  • 竞争仪表板
  • 公司简介
    • Associated British Foods Plc (spi Pharma Inc.)
    • Adjuvatis
    • Agenus Inc.
    • Aphios Corporation
    • Vertellus
    • Croda International PLC
    • CSL Limited
    • Dynavax Technologies Corporation
    • GlaxoSmithKline PLC
    • InvivoGen
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2118

REPORT HIGHLIGHT

Vaccine Adjuvants Market size was valued at USD 712.5 Million in 2022, expanding at a CAGR of 7.2% from 2023 to 2030.

Vaccine adjuvants are components integrated into vaccines to heighten the body's immune response triggered by the vaccine's antigen, which stimulates the immune system. These adjuvants function by amplifying the body's immune reaction, thereby enhancing the vaccine's effectiveness by bolstering the immune response and often permitting the use of smaller antigen amounts. They can induce a more robust and longer-lasting immune response, thereby elevating defense against the targeted disease. Adjuvants also aid in enhancing vaccine efficacy for specific populations, such as the elderly or individuals with compromised immune systems. Diverse adjuvant types encompass aluminum salts (like aluminum hydroxide or aluminum phosphate), oil-in-water emulsions (such as MF59 or AS03), toll-like receptor agonists, among others. Adjuvants are pivotal in vaccine development, facilitating the creation of more potent vaccines against various infectious diseases and augmenting overall vaccine effectiveness and the endurance of immune responses.

Vaccine Adjuvants Market- Market Dynamics

Increasing prevalence of infectious diseases to propel market demand

The prevalence of infectious diseases like influenza, tuberculosis, cholera, polio, measles, malaria, and HIV has escalated. According to the WHO, TB ranked as the 13th leading cause of death globally and stood as the second-leading infectious cause of death after COVID-19 in 2021, with almost 1.6 million reported deaths worldwide, including 187,000 individuals with HIV. The surge in cases has put immense pressure on vaccine production, as an increased number of vaccines are necessary to combat such contagious diseases, consequently heightening the demand for adjuvants.

Vaccine Adjuvants Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.2% over the forecast period (2023-2030)
  • Based on product type segmentation, adjuvant emulsions was predicted to show maximum market share in the year 2022
  • Based on application segmentation, commercial was the leading type in 2022
  • Based on Usage Type segmentation, Active Immunostimulants was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Vaccine Adjuvants Market- Segmentation Analysis:

The Global Vaccine Adjuvants Market is segmented on the basis of Product Type, Application, Usage Type, Disease Area, and Region.

The market is divided into eight categories based on product type: Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP) and Others. Based on product categorization, the adjuvant emulsions segment is forecasted to uphold its leading position during he forecat period. This is primarily accredited to the escalating prevalence of communicable diseases, propelling the usage of emulsion adjuvants in vaccines and consequently nurturing the expansion of this specific segment.

The market is divided into two categories based on application: research and commercial. The commercial sector dominates the market and is likely to maintain its dominance during the forecast period. With the rise in infectious diseases and ongoing public health concerns globally, there's a growing need for effective vaccines. Adjuvants contribute significantly to developing vaccines that offer improved protection, enabling healthcare systems to expand vaccination programs, especially in regions where there is a high prevalence of infectious diseases.

Vaccine Adjuvants Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Vaccine Adjuvants Market- Competitive Landscape:

The market for vaccine adjuvants is currently undergoing strategic advancements directed at enhancing both the efficacy and safety of vaccines. These innovations concentrate on pioneering adjuvant formulations and delivery systems, aiming to intensify immune responses while upholding safety standards. Significant research and development endeavors are directed towards tailoring adjuvants specifically for distinct vaccines, thereby augmenting their effectiveness across diverse demographic groups. Moreover, collaborations among pharmaceutical firms, research institutions, and regulatory bodies are propelling the development and validation of adjuvants, especially for emerging infectious diseases and challenging pathogens. Market dynamics center around regulatory adherence, cost-efficiency, and scalability, setting the stage for transformative adjuvant technologies that fortify vaccine responses and contribute to global public health improvements.

Recent Developments:

In January 2023, Elicio Therapeutics, specializing in lymph node-targeted adjuvants as well as vaccines for violent cancers along with infectious illnesses, finalized a union agreement with Angion Biomedica Corp. The focus lies on advancing Elicio's exclusive lymph node-targeting Amphiphile expertise to progress immunotherapies, primarily concentrating on ELI-002, a therapeutic cancer vaccine aimed at mKRAS-driven tumors.

In November 2022, Hubro Therapeutics AS acquired the GM-CSF vaccine adjuvant from Targovax ASA through an asset purchase agreement, involving a cash payment of NOK10 million. Hubro is continuing the development of GM-CSF as an adjuvant for its range of innovative cancer vaccines in its pipeline.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE ADJUVANTS MARKET KEY PLAYERS

  • Associated British Foods Plc (spi Pharma Inc.)
  • Adjuvatis
  • Agenus Inc.
  • Aphios Corporation
  • Vertellus
  • Croda International PLC
  • CSL Limited
  • Dynavax Technologies Corporation
  • GlaxoSmithKline PLC
  • InvivoGen
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE

  • Mineral Salt-based Adjuvant
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Liposome Adjuvants
  • Carbohydrate Adjuvants
  • Bacteria-derived Adjuvants
  • Virus-like Particles (VLP)
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY APPLICATION

  • Research Applications
  • Commercial Applications

GLOBAL VACCINE ADJUVANTS MARKET, BY USAGE TYPE

  • Active Immunostimulants
  • Carriers
  • Vehicle Adjuvants

GLOBAL VACCINE ADJUVANTS MARKET, BY DISEASE AREA

  • Infectious Disease
  • Cancer
  • Others

GLOBAL VACCINE ADJUVANTS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Adjuvants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Adjuvants Market Snippet by Product Type
    • 2.1.2. Vaccine Adjuvants Market Snippet by Application
    • 2.1.3. Vaccine Adjuvants Market Snippet by Usage Type
    • 2.1.4. Vaccine Adjuvants Market Snippet by Disease Area
    • 2.1.5. Vaccine Adjuvants Market Snippet by Country
    • 2.1.6. Vaccine Adjuvants Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Adjuvants Key Market Trends

  • 3.1. Vaccine Adjuvants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Adjuvants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Adjuvants Market Opportunities
  • 3.4. Vaccine Adjuvants Market Future Trends

4. Vaccine Adjuvants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Adjuvants Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Adjuvants Market Landscape

  • 6.1. Vaccine Adjuvants Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Adjuvants Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Mineral Salt-based Adjuvant
    • 7.1.3. Tensoactive Adjuvants
    • 7.1.4. Adjuvant Emulsions
    • 7.1.5. Liposome Adjuvants
    • 7.1.6. Carbohydrate Adjuvants
    • 7.1.7. Bacteria-derived Adjuvants
    • 7.1.8. Virus-like Particles (VLP)
    • 7.1.9. Others

8. Vaccine Adjuvants Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Research Applications
    • 8.1.3. Commercial Applications

9. Vaccine Adjuvants Market - By Usage Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Usage Type, 2022 & 2030 (%)
    • 9.1.2. Active Immunostimulants
    • 9.1.3. Carriers
    • 9.1.4. Vehicle Adjuvants

10. Vaccine Adjuvants Market - By Disease Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Infectious Disease
    • 10.1.3. Cancer
    • 10.1.4. Others

11. Vaccine Adjuvants Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Adjuvants Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Adjuvants Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Adjuvants Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Adjuvants Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Adjuvants Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Usage Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Disease Area, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Vaccine Adjuvants Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Associated British Foods Plc (spi Pharma Inc.)
    • 12.2.2. Adjuvatis
    • 12.2.3. Agenus Inc.
    • 12.2.4. Aphios Corporation
    • 12.2.5. Vertellus
    • 12.2.6. Croda International PLC
    • 12.2.7. CSL Limited
    • 12.2.8. Dynavax Technologies Corporation
    • 12.2.9. GlaxoSmithKline PLC
    • 12.2.10. InvivoGen
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Adjuvants Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Adjuvants Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Adjuvants Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Usage Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Usage Type
  • TABLE Global Vaccine Adjuvants Market, by Usage Type 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Disease Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Area
  • TABLE Global Vaccine Adjuvants Market, by Disease Area 2018-2030 (USD Million)
  • TABLE Vaccine Adjuvants Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Adjuvants Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Usage Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Adjuvants Market, by Disease Area, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Adjuvants Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Usage Type segment market share analysis, 2022 & 2030
  • FIGURE Usage Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Area segment market share analysis, 2022 & 2030
  • FIGURE Disease Area segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Europe Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Asia Pacific Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Latin America Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Germany Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE India Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Brazil Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Adjuvants Market share analysis by country, 2022
  • FIGURE Saudi Arabia Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Adjuvants Market size, forecast and trend analysis, 2018 to 2030 (USD Million)